Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Alere Inc    ALR

Delayed Quote. Delayed  - 07/26 04:03:11 pm
43.895 USD   -0.06%
07/20 ABBOTT LABORATO : CEO remains noncommittal on Alere deal
07/15DJU.S. HOT STOCKS : Hot Stocks to Watch
07/14 ALERE INC. : Announces Update on Form 10-K
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Alere Inc : Alere Inc. Schedules Conference Call for 8:30 a.m. ET February 8, 2012 to Discuss Fourth Quarter 2011 Results

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/01/2012 | 09:20pm CEST

WALTHAM, Mass., Feb. 1, 2012 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, today announced that it will release its fourth quarter 2011 earnings on Wednesday, February 8, 2012. The Company will also host a conference call beginning at 8:30 a.m. (Eastern Time) on that date to discuss these results and other corporate matters. During the conference call, the Company will discuss and answer questions concerning business and financial developments and trends. The Company's responses to questions, as well as other matters discussed during the conference call, may contain or constitute information that has not been disclosed previously.

The conference call may be accessed by dialing (800) 860-2442 (domestic) or (412) 858-4600 (international) and asking for Alere Inc. A webcast of the call can also be accessed via the Alere website at www.alere.com/investors, or directly through the following link: http://www.videonewswire.com/event.

A replay will be available approximately four hours after the conclusion of the call and will remain available for a period of seven days following the call. The replay may be accessed by dialing (877) 344-7529 (domestic) or (412) 317-0088 (international) and entering replay code 10009812. The replay will also be available via online webcast at http://www.videonewswire.com/event or via the Alere website at www.alere.com/investors for a period of 60 days following the call.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Alere enables individuals to take charge of improving their health and quality of life at home. Alere's global leading products and services, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, toxicology and women's health. Alere is headquartered in Waltham, Massachusetts.

For additional information on Alere, please visit www.alere.com.

SOURCE Alere Inc.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ALERE INC
07/20 ABBOTT LABORATORIES : CEO remains noncommittal on Alere deal
07/15DJU.S. HOT STOCKS : Hot Stocks to Watch
07/14 ALERE INC. : Results of Operations and Financial Condition, Financial Statements..
07/14 ALERE INC. : Announces Update on Form 10-K
07/14DJALERE : Expects to Restate Financial Results
07/13 ALERE : trade; HIV Combo Test Receives WHO Prequalification
07/13 ALERE : TM) HIV Combo Test Receives WHO Prequalification
07/12 ALERE INC. : Material Impairments, Financial Statements and Exhibits (form 8-K)
07/12DJALERE : to Voluntarily Pull Blood-Monitoring Devices
07/11 ALERE : to Initiate Voluntary Withdrawal of the Alere INRatio® and INRatio®2 PT/..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
07/25DJADRs End Lower; Philips Rises
07/25DJPHILIPS : Cost Savings, Strong Sales Boost Philips' Earnings
07/25DJPHILIPS : Profit Lifted by Health Technology Business
07/21 MCKESSON : Theranos hires executives in regulatory, compliance push
07/21DJTheranos Hires Compliance, Regulatory Executives
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
07/21 M&A Target Pops Over 50% - What Next?
07/21 FDA panel review underway for Dexcom diabetes monitor, Alere POC diabetes tes..
07/15 Jessica Alba Puts Honest On The Block
07/15 Alere almost there with 2015 10-K filing; analysts say Abbott deal on track; ..
07/12 Alere voluntarily withdraws INRatio and INRatio2 PT/INR Monitoring System fro..